EQUITY

12 Months Ended

Dec. 31, 2012

EQUITY [Abstract]

EQUITY

NOTE 9:- EQUITY

a. Share capital:

Ordinary shares confer upon their holders voting rights, the right to receive cash dividends and the right to share in excess assets upon liquidation of the Company.

b. Stock Option Plans:

Description of Plans

The Company has four stock option plans, the 1995 and the 2003 Stock Option and Incentive Plans and the 2005 and 2008 Stock Incentive Plans (the "Plans"). The 1995 Plan expired and there are no options outstanding under this plan. Under the 2003 Plan, options may be granted to employees, officers, directors and consultants of the Company.

As of December 31, 2012, an aggregate of 419,120 shares of the Company are still available for future grants under the 2003 Plan.

The exercise price per share under the 1995 Plan was not less than the market price of an Ordinary share at the date of grant. The exercise price per share under the 2003 Plan is the higher of (i) $ 5.00 per share; and (ii) the market value of the shares as of the date of the option grant, unless otherwise provided in the stock option agreement.

In December 2005, the Company's shareholders approved the adoption of a new plan, the 2005 Plan with 1,500,000 shares or stock options available for grant. In October 2008, the Company's Board of Directors approved the adoption of a sub-plan to enable qualified optionees certain tax benefits under the Israeli Income Tax Ordinance.

The 2005 plan expired in 2012 although there are still options and RSU's outstanding under the plan.

In October 2008, the compensation stock option committee of the Company's Board of Directors approved the adoption of a new plan, the 2008 Plan with 1,000,000 shares or stock options available for grant and a sub-plan to enable qualified optionees certain tax benefits under the Israeli Income Tax Ordinance. Among the incentives that may be adopted are share options, performance share awards, performance share unit awards, restricted shares, restricted share unit awards and other stock-based awards. In October 2010 and April 2012 the Company's Board of Directors approved an increase in the number of shares or stock options available for grant under the 2008 Plan for an aggregate of 3,000,000 shares to a total of 4,000,000 shares available for future grants. As of December 31, 2012, an aggregate of 356,190 shares of the Company are still available for future grants under the 2008 Plan.

Options granted under the Plans above generally vest quarterly over two to four years. The options expire six, seven or ten years from the date of grant. RSUs granted under the Plans above (excluding the 2003 plan) vest quarterly or annually over four years. Any options or RSUs, which are forfeited or canceled before expiration, become available for future grants.

Valuation Assumptions

The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The option-pricing model requires a number of assumptions, of which the most significant are expected stock price volatility and the expected option term. Expected volatility was calculated based upon actual historical stock price movements.

The expected option term represents the period that the Company's stock options are expected to be outstanding and are based on historical incidence of exercise of options. The expected term of options granted is based upon historical experience complying with SAB 110. The risk-free interest rate is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.

Options granted to Employees and Non-employees

The fair value of the Company's stock options granted to employees for the years ended December 31, 2012, 2011 and 2010 was estimated using the following weighted average assumptions:

	Year ended December 31,
	2012	2011	2010
Risk free interest	0.68%	0.99%	1.70%
Dividend yields	0%	0%	0%
Volatility	45%	44%	45%
Expected term (in years)	5	5	4.75

The fair value of the Company's stock options granted to non-employees for the year ended December 31, 2010 was estimated using the following weighted average assumptions: risk free interest of 3.16%, dividend yield of 0%, volatility of 48% and expected term of 7 years.

No options were granted to non-employees during the year ended December 31, 2011. The fair value of the Company's stock options granted to non-employees for the year ended December 31, 2012 was estimated using the following weighted average assumptions: risk free interest of 0.79%, dividend yield of 0%, volatility of 45% and expected term of 6.0 years.

A summary of employee option balances under the Plans as of December 31, 2012 and changes during the year ended December 31, 2012 are as follows:

	Number of options			Weighted-average exercise price		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value (in thousands)
Outstanding at January 1, 2012		4,996,438		$	5.5		4.0	$	28
Granted		1,150,000		$	3.4
Exercised		(56,000	)	$	4.1
Expired		(8,938	)	$	77.6
Forfeited		(201,702	)	$	5.7
Outstanding at December 31, 2012		5,879,798		$	5.0		3.6	$	3,831
Exercisable at December 31, 2012		4,150,546		$	5.6		2.8	$	1,008
Vested and expected to vest at December 31, 2012		5,742,704		$	5.0		3.6	$	3,580

A summary of employee option balances under the Plans as of December 31, 2011 and 2010 and changes during the years ended on those dates are as follows:

	Year ended December 31,
	2011					2010
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
Options outstanding at beginning of year		4,204,114		$	6.5		4,187,555		$	6.8
Granted		900,000		$	4.2		60,000		$	4.8
Exercised		-					(3,000	)	$	5.3
Expired		(37,937	)	$	82.1		(592	)	$	1,113.3
Forfeited		(69,739	)	$	8.2		(39,849	)	$	14.5
Options outstanding at end of year		4,996,438		$	5.5		4,204,114		$	6.5
Options exercisable at end of year		4,030,521		$	5.8		3,903,132		$	6.6

A summary of non-employee option balances under the Plans as of December 31, 2012 and changes during the year ended December 31, 2012 are as follows:

	Number of options			Weighted-average exercise price		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value (in thousands)
Outstanding at January 1, 2012		365,000		$	6.0		5.3	$	-
Granted		20,000		$	3.0
Exercised		-
Expired		-
Forfeited		(350,000	)	$	6.0
Outstanding at December 31, 2012		35,000		$	4.1		5.1	$	46
Exercisable at December 31, 2012		7,125		$	5.7		4.6	$	-
Vested and expected to vest at December 31, 2012		29,563		$	4.2		5.1	$	39

A summary of non-employee option balances under the Plans as of December 31, 2011 and 2010 and changes during the years ended on those dates are as follows:

	Year ended December 31,
	2011				2010
	Number of options		Weighted average exercise price		Number of options		Weighted average exercise price
Options outstanding at beginning of year		365,000	$	6.0		-
Granted		-				365,000	$	6.0
Exercised		-				-
Expired		-				-
Forfeited		-				-
Options outstanding at end of year		365,000	$	6.0		365,000	$	6.0
Options exercisable at end of year		178,188	$	6.0		54,728	$	6.0

The weighted-average grant-date fair value of options granted to employees during the years ended December 31, 2012, 2011 and 2010 was $ 1.36, $ 1.46 and $ 1.93, respectively. The weighted-average grant-date fair value of options granted to non-employees during the years ended December 31, 2012 and 2010 was $ 1.24 and $ 2.82, respectively. The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the year 2012 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2012. These amounts change based on the fair market value of the Company's stock. Total intrinsic value of options exercised for the years ended December 31, 2012, 2011 and 2010 was approximately $ 65, nil and 1, respectively.

Total grant-date fair value of options and RSUs granted to employees that vested during the years ended December 31, 2012, 2011 and 2010 was approximately $ 1,867, $ 1,713 and $ 1,444, respectively.

Total grant-date fair value of options and RSUs granted to consultants that vested during the years ended December 31, 2012, 2011 and 2010 was approximately $ 134, $ 371 and $ 179, respectively.

The outstanding and exercisable options granted to employees under the Company's Stock Option Plans as of December 31, 2012, have been separated into ranges of exercise price as follows:

									Weighted
	Options		Weighted				Options		average
	outstanding		average		Weighted		exercisable		exercise
Ranges of	as of		remaining		Average		as of		price of
Exercise	December 31,		contractual		Exercise		December 31,		exercisable
Price	2012		life (years)		Price		2012		options
$ 3.00 - 4.30		1,950,000		4.5	$	3.5		601,750	$	4.0
$ 4.54 - 6.77		3,784,898		3.2	$	5.6		3,403,896	$	5.7
$ 7.48 - 9.20		144,900		1.8	$	7.8		144,900	$	7.8
		5,879,798		3.6	$	5.0		4,150,546	$	5.6

The outstanding and exercisable options granted to non-employees under the Company's Stock Option Plans as of December 31, 2012, have been separated into ranges of exercise price as follows:

Ranges of Exercise Price	Options Outstanding as of December 31, 2012		Weighted average remaining contractual life (years)		Weighted Average Exercise Price		Options exercisable as of December 31, 2012		Weighted average exercise price of exercisable options
$ 3.00 - 5.65		35,000		5.1	$	4.1		7,125	$	5.7

Restricted Share Units ("RSUs") granted to Employees and Non-employees

The fair value of RSUs is estimated based on the market value of the Company's stock on the date of the award.

During 2012, 2011 and 2010, the Company granted 1,112,500, 132,000 and 597,000 RSUs, respectively. The entitlement to these RSUs vests over a four-year period (15%, 25%, 30% and 30% each year, respectively) in quarterly or in annual trenches. The following table summarizes information regarding the number of RSUs issued and outstanding as of December 31, 2012, 2011 and 2010 and changes during the years ended on those dates:

Employees:

	Year ended December 31,
	2012					2011					2010
	Number of RSUs			Weighted average grant date fair value		Number of RSUs			Weighted average grant date fair value		Number of RSUs			Weighted average grant date fair value
RSUs outstanding at the beginning of the year		846,147		$	4.2		1,326,433		$	3.8		1,225,025		$	3.2
Granted		1,112,500		$	3.9		132,000		$	4.2		567,000		$	5.5
Vested		(445,731	)	$	3.4		(473,973	)	$	3.3		(417,029	)	$	2.9
Forfeited		(164,464	)	$	5.1		(138,313	)	$	4.0		(48,563	)	$	2.7
RSUs outstanding at the end of the year		1,348,452		$	4.1		846,147		$	4.2		1,326,433		$	3.8

Non-employees:

	Year ended December 31,
	2012					2011					2010
	Number of RSUs			Weighted average grant date fair value		Number of RSUs			Weighted average grant date fair value		Number of RSUs			Weighted average grant date fair value
RSUs outstanding at the beginning of the year		32,250		$	4.7		42,000		$	4.5		17,000		$	2.7
Granted		-					-					30,000		$	5.2
Vested		(13,000	)	$	4.0		(9,750	)	$	3.6		(5,000	)	$	2.7
Forfeited		-					-					-
RSUs outstanding at the end of the year		19,250		$	5.2		32,250		$	4.7		42,000		$	4.5

Additional Stock-based Compensation Data

As of December 31, 2012, there was approximately $ 7,394 of unrecognized compensation costs related to non-vested stock-based compensation arrangements granted to employees under the Plans and approximately $ 75 of unrecognized compensation costs related to non-vested stock-based compensation arrangements granted to non-employees under the Plans. The cost related to employees is expected to be recognized over a weighted-average period of 1.70 years and the cost related to non-employees is expected to be recognized over the weighted-average period of 1.84 years.

c. In October 2011, the Company approved the grant of 400,000 stock options to its incoming Chief Executive Officer ("CEO") (such service commenced on January 1, 2012) at an exercise price of $ 3.88 per share. These options vest over a four-year period (15%, 25%, 30% and 30% each year, respectively) in quarterly trenches. The fair value of these options was estimated at $ 580, using the Black-Scholes option-pricing valuation model which is expected to be recognized over a weighted-average period of 2.38 years. This grant is included in the above tables related to employees.

d. In December 2011, the Company approved the grant of 500,000 stock options to its Chairman of the Board of Directors and then CEO )as of January 1, 2012 he ceased to be CEO( and the other members of the Board of Directors at an exercise price of $ 4.5425 per share. These options vest ratably, each quarter, over a three-year period. The fair value of these options was estimated at $ 656, using the Black-Scholes option-pricing valuation model which is expected to be recognized over a weighted-average period of 1.42 years. These grants are included in the above tables as employee grants. Three directors who were granted 150,000 stock options as part of the above grants were replaced as directors in December 2012, and their unvested options were forfeited.

e. In December 2012, the Company approved the grant of 150,000 stock options to three new directors (out of which 100,000 stock options were granted to FIMI IV 2007 LTD, a shareholder in the Company, in connection with director services provided by two new directors) at an exercise price of $ 5.31 per share. These options vest ratably, each quarter, over a three year period. The fair value of these options was estimated at $ 299, using the Black-Scholes option-pricing valuation model which is expected to be recognized over a weighted-average period of 1.63 years. These grants are included in the above tables as employee grants.

f. Dividends:

1. In the event that cash dividends are declared by the Company, such dividends will be declared and paid in Israeli currency. Under current Israeli regulations, any cash dividend in Israeli currency paid in respect of ordinary shares purchased by non-residents of Israel with non-Israeli currency, may be freely repatriated in such non-Israeli currency, at the exchange rate prevailing at the time of repatriation. The Company does not expect to pay cash dividends in the foreseeable future.

2. Pursuant to the terms of a credit line from a bank (see also Note 13), the Company is restricted from paying cash dividends to its shareholders without initial approval from the bank.